American Oncology Network Vista Oncology Division — Olympia, Washington

American Oncology Network Vista Oncology Division is a clinical research site located in Olympia, Washington, United States 98502.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

American Oncology Network Vista Oncology Division has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Sponsors: Shanghai Henlius Biotech, Rigel Pharmaceuticals, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Olympia

Browse all research sites in Washington · View every site in Olympia

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for American Oncology Network Vista Oncology Division?

American Oncology Network Vista Oncology Division has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has American Oncology Network Vista Oncology Division conducted?

American Oncology Network Vista Oncology Division has 6 clinical trials on record, with 5 currently active. Their work covers Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Is American Oncology Network Vista Oncology Division accredited by Crixeo Clinical Trials?

American Oncology Network Vista Oncology Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about American Oncology Network Vista Oncology Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.